Home / Pharma Healthcare / Japan Biosimilar Drug Market Report 2016

Japan Biosimilar Drug Market Report 2016

  • Id : RNR-22418
  • Category : Pharma Healthcare
  • Publish Date : 11-Oct
  • Pages : 118
  • Format : PDF
License Type

Description
Notes:
Sales, means the sales volume of Biosimilar Drug
Revenue, means the sales value of Biosimilar Drug

This report studies sales (consumption) of Biosimilar Drug in Japan market, focuses on the top players, with sales, price, revenue and market share for each player, covering
    Hospira
    Sandoz
    Teva Pharmaceutical Industries
    Pfizer
    Merck Sharp & Dohme
    Celltrion
    Amgen
    Biogen
    Mylan
    Biocon
    Dr. Reddy?s Laboratories
    Boehringer Ingelheim GmbH
    Intas Pharmaceuticals
    LG Life Sciences
    Emcure Pharmaceuticals
    Probiomed
    Biosidus
    3SBio
    WOCKHARDT
    Sun Pharmaceutical Industries
    Shanghai Fosun Pharmaceutical
    Qilu Pharmaceutical
    Allergan
    Dongbao
    Samsung Biologics
    Zydus Cadila.
    Dong-A Pharmaceutical

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
    Type I
    Type II
    Type III
Split by applications, this report focuses on sales, market share and growth rate of  Biosimilar Drug in each application, can be divided into
    Application 1
    Application 2
    Application 3